FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arredondo, J.
Right arrow Articles by Grando, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arredondo, J.
Right arrow Articles by Grando, S. A.
(The FASEB Journal. 2006;20:2093-2101.)
© 2006 FASEB

Receptor-mediated tobacco toxicity: cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of {alpha}7 nicotinic receptor in oral keratinocytes

Juan Arredondo*, Alexander I. Chernyavsky*, David L. Jolkovsky{ddagger}, Kent E. Pinkerton{dagger} and Sergei A. Grando*,1

* Department of Dermatology and

{dagger} Center for Health and the Environment, University of California, Davis; and

{ddagger} Section of Periodontics, School of Dentistry, University of California, Los Angeles, California, USA

1Correspondence: Department of Dermatology, University of California Davis Medical Center, 3301 C St., Ste. 1400, Sacramento, CA 95816, USA. E-mail: sagrando{at}ucdavis.edu

The use of tobacco products is associated with an increased incidence of periodontal disease, poor response to periodontal therapy, and a high risk for developing head and neck cancer. Nicotine and tobacco-derived nitrosamines have been shown to exhibit their pathobiologic effects due in part to activation of the nicotinic acetylcholine (ACh) receptors (nAChRs), mainly {alpha}7 nAChR, expressed by oral keratinocytes (KCs). This study was designed to gain mechanistic insight into {alpha}7-mediated morbidity of tobacco products in the oral cavity. We investigated the signaling pathways downstream of {alpha}7 nAChR in monolayers of oral KCs exposed for 24 h to aged and diluted sidestream cigarette smoke (ADSS) or an equivalent concentration of pure nicotine. By both real-time polymerase chain reaction (PCR) and In-cell Western, the KCs stimulated with ADSS or nicotine showed multifold increases of STAT-3. These effects could be completely blocked or significantly (P<0.05) diminished if the cells were pretreated with the {alpha}7 antagonist {alpha}-bungarotoxin ({alpha}BTX) or transfected with anti-{alpha}7 small interfering RNA (siRNA-{alpha}7). The use of pathway inhibitors revealed that signaling through the Ras/Raf-1/MEK1/ERK steps mediated {alpha}7-dependent up-regulation of STAT-3. Targeted mutation of the {alpha}7 gene prevented ERK1/2 activation by nicotine. Using the gel mobility shift assay, we demonstrated that an increased protein binding activity of STAT-3 caused by ADSS or pure nicotine was mediated by janus-activated kinase (JAK)-2. Activation of JAK-2/STAT-3 pathway could be prevented by {alpha}BTX or siRNA-{alpha}7. Thus, nuclear transactivation of STAT-3 in KCs exposed to tobacco products is mediated via intracellular signaling downstream from {alpha}7, which proceeds via two complementary pathways. The Ras/Raf-1/MEK1/ERK cascade culminates in up-regulated expression of the gene encoding STAT-3, whereas recruitment and activation of tyrosine kinase JAK-2 phosphorylates it. Elucidation of this novel mechanism of nicotine-dependent nuclear transactivation of STAT-3 identifies oral {alpha}7 nAChR as a promising molecular target to prevent, reverse, or retard tobacco-related periodontal disease and progression of head and neck cancer by receptor inhibitors.—Arredondo, J., Chernyavsky, A. I., Jolkovsky, D. L., Pinkerton, K. E., Grando, S. A. Receptor-mediated tobacco toxicity: cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of {alpha}7 nicotinic receptor in oral keratinocytes.


Key Words: nicotinic ACh receptors • gene expression • oral cancer • periodontal therapy




This article has been cited by other articles:


Home page
FASEB J.Home page
J. Arredondo, A. I. Chernyavsky, D. L. Jolkovsky, K. E. Pinkerton, and S. A. Grando
Receptor-mediated tobacco toxicity: acceleration of sequential expression of {alpha}5 and {alpha}7 nicotinic receptor subunits in oral keratinocytes exposed to cigarette smoke
FASEB J, May 1, 2008; 22(5): 1356 - 1368.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. I. Chernyavsky, J. Arredondo, T. Piser, E. Karlsson, and S. A. Grando
Differential Coupling of M1 Muscarinic and {alpha}7 Nicotinic Receptors to Inhibition of Pemphigus Acantholysis
J. Biol. Chem., February 8, 2008; 283(6): 3401 - 3408.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Q. Zhang, X. Tang, Z.-F. Zhang, R. Velikina, S. Shi, and A. D. Le
Nicotine Induces Hypoxia-Inducible Factor-1{alpha} Expression in Human Lung Cancer Cells via Nicotinic Acetylcholine Receptor Mediated Signaling Pathways
Clin. Cancer Res., August 15, 2007; 13(16): 4686 - 4694.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The Federation of American Societies for Experimental Biology.